申请人:Rhone-Poulenc Rorer Pharmaceuticals Inc.
公开号:US05041453A1
公开(公告)日:1991-08-20
This invention relates to certain quinolinyl-benzoheterobicyclic compounds and their use as valuable pharmaceutical agents, particularly as lipoxygenase inhibitors and/or leukotriene antagonists and/or as mediator release inhibitors useful as anti-inflammatory and anti-allergic agents.
这项发明涉及某些喹啉基苯并杂环化合物及其作为有价值的药用制剂的用途,特别是作为脂氧合酶抑制剂和/或白三烯拮抗剂和/或介质释放抑制剂,可用作抗炎和抗过敏剂。